Published: Mar 1, 2026
Written by Klarity Editorial Team
Published: Mar 1, 2026

If you’re struggling with binge eating disorder (BED) and wondering whether you can access treatment through telehealth, you’re not alone. Millions of Americans are turning to virtual healthcare for mental health support, and the good news is that telehealth is a fully legal and effective way to get evaluated and treated for BED in 2026.
This comprehensive guide will walk you through everything you need to know about getting BED medications like Topamax (topiramate) and Wellbutrin (bupropion) through telehealth—including federal and state regulations, who can prescribe, safety considerations, and what to expect during your virtual appointments.
Binge eating disorder is the most common eating disorder in the United States, affecting people of all ages, genders, and backgrounds. It’s characterized by recurring episodes of eating large amounts of food in a short period, feeling out of control during these episodes, and experiencing significant distress—without the compensatory purging behaviors seen in bulimia.
While therapy remains a cornerstone of BED treatment, certain medications have shown promise in reducing binge frequency and helping patients regain control. The challenge? Many people face barriers to in-person psychiatric care, including long wait times, limited specialist availability, and geographic constraints.
Telehealth bridges this gap. Virtual mental health platforms now connect patients with licensed providers who can evaluate, diagnose, and prescribe medications for BED—all from the comfort and privacy of home.
Here’s the most important thing to understand: medications commonly used for BED treatment—specifically Topamax (topiramate) and Wellbutrin (bupropion)—are not controlled substances. This distinction is crucial because it means they’re exempt from the strict federal telehealth restrictions that apply to controlled medications.
The Ryan Haight Act of 2008, which typically requires an in-person medical evaluation before prescribing controlled substances via telehealth, does not apply to non-controlled medications. This means that from a federal perspective, licensed providers can prescribe these BED medications via telehealth without any mandatory in-person visit requirement.
While Vyvanse (lisdexamfetamine) is the only FDA-approved medication specifically for BED, it’s a Schedule II controlled substance. The DEA has extended pandemic-era flexibilities for controlled substance prescribing through December 31, 2026, but most reputable telehealth platforms don’t prescribe controlled stimulants for BED due to abuse potential and regulatory complexity.
Instead, they focus on evidence-based off-label medications like topiramate and bupropion, which offer therapeutic benefits without controlled substance restrictions.
While federal law sets the baseline, each state has its own telehealth regulations. The good news? Most states have permanently adopted or expanded telehealth prescribing flexibility that was first introduced during the COVID-19 pandemic.
The majority of states, including California, New York, Texas, Florida, Michigan, Wisconsin, and Delaware, have no in-person visit requirement for non-controlled medication prescriptions via telehealth. In these states, a comprehensive virtual evaluation meets the legal standard for establishing a patient-provider relationship and prescribing appropriate medications.
California even went a step further in 2025, with Assembly Bill 1503 clarifying that asynchronous telehealth (including detailed online questionnaires) can constitute a ‘good faith exam’ for prescribing purposes, as long as it meets the standard of care.
A handful of states—including Alabama, Georgia, and New Hampshire—require periodic in-person visits for ongoing telehealth care:
Alabama requires an in-person visit within 12 months if you’ve had more than four consecutive telehealth visits for the same condition. This can be satisfied by seeing any collaborating provider in person, not necessarily your telehealth prescriber.
Georgia asks providers to ‘attempt’ an annual in-person examination for continued telemedicine treatment, though the initial evaluation can be conducted entirely via telehealth.
New Hampshire updated its law in 2025 to allow telehealth initiation of treatment but requires at least one in-person follow-up visit within 12 months for certain medication classes.
Even in these states, you can start treatment entirely online—the in-person requirement only applies to long-term continuation of care.
South Carolina explicitly allows telehealth prescribing as long as the provider conducts an ‘appropriate evaluation,’ which state regulations confirm ‘need not be in-person’ if adequate via telemedicine technology. However, legislation to grant nurse practitioners full practice authority in the state is still pending.
Licensed medical doctors and doctors of osteopathic medicine can prescribe Topamax and Wellbutrin for BED via telehealth in all 50 states, provided they’re licensed in your state of residence.
The landscape for nurse practitioner practice authority has evolved dramatically. As of 2025, 34 states plus Washington, D.C. grant nurse practitioners full practice authority, meaning they can evaluate, diagnose, and prescribe medications independently without physician oversight.
Recent additions to this list include:
In these states, an NP working for a telehealth platform like Klarity Health can provide your entire BED treatment independently, from initial evaluation through ongoing medication management.
In states without full practice authority—such as Texas, Florida, Georgia, and Alabama—NPs can still prescribe these non-controlled medications, but they must work under a collaborative agreement with a physician. This is typically a behind-the-scenes arrangement that doesn’t affect your care experience; you’ll see the NP for appointments, but a supervising physician reviews and co-signs prescriptions.
Physician assistants can also prescribe Topamax and Wellbutrin for BED under delegated authority from a supervising physician in all states. Like NPs in collaborative practice states, this supervision requirement is usually administrative and doesn’t impact your patient experience.
What it is: Topiramate is an anticonvulsant medication FDA-approved for seizure prevention and migraine prophylaxis. For BED, it’s prescribed off-label based on research showing it can reduce binge frequency and support weight management.
How it works for BED: Topiramate appears to modulate neurotransmitters involved in appetite regulation and impulse control, helping some patients reduce the frequency and intensity of binge episodes.
Typical dosing: Providers usually start with a low dose (25mg) and gradually increase over weeks to minimize side effects. Therapeutic doses for BED typically range from 75-200mg daily.
Important safety considerations:
Telehealth accessibility: ✅ Fully available via telehealth in all states with no in-person requirement (except periodic follow-up in AL, GA, NH for long-term treatment)
What it is: Bupropion is an atypical antidepressant FDA-approved for major depressive disorder and smoking cessation. It’s used off-label for BED based on evidence suggesting it can reduce binge eating behaviors.
How it works for BED: Bupropion affects dopamine and norepinephrine pathways, which may help regulate mood, reduce impulsive eating behaviors, and curb appetite in some patients.
Typical dosing: Usually started at 150mg once daily (extended-release formulation) and may be increased to 300mg after several weeks based on response and tolerability.
Important safety considerations:
Telehealth accessibility: ✅ Fully available via telehealth in all states with no federal or state-level in-person requirements
You might wonder why your provider is prescribing medications that aren’t FDA-approved specifically for BED. Off-label prescribing is a common, legal, and medically appropriate practice when supported by clinical evidence.
The reality is that only one medication—Vyvanse, a controlled stimulant—has FDA approval for BED. Yet research demonstrates that topiramate and bupropion can be effective alternatives, particularly for patients who:
Reputable telehealth providers will clearly explain that they’re prescribing off-label, discuss the evidence supporting this approach, obtain your informed consent, and monitor you appropriately.
A legitimate telehealth evaluation for BED should be comprehensive—typically 30-45 minutes for an initial consultation. Your provider will:
Assess BED diagnostic criteria: Expect detailed questions about:
Review medical history: Including:
Mental health screening: Assessment for:
Physical health review:
Don’t be surprised when your provider verifies your identity and confirms your physical location at the start of the visit. This isn’t invasive—it’s legally required in many states to ensure:
Your provider should:
At Klarity Health, our providers take time to ensure patients understand their treatment options and feel comfortable with the plan before moving forward.
Once your provider determines that medication is appropriate, they’ll electronically send your prescription to the pharmacy of your choice. This should be a licensed retail pharmacy or legitimate mail-order service—never directly from the telehealth company’s own ‘pharmacy.’
Prescription Monitoring Programs (PMPs): While most states don’t legally require PMP checks for non-controlled medications like topiramate and bupropion, responsible providers may still review your medication history to:
Medication management for BED isn’t a ‘set it and forget it’ situation. Expect:
Initial phase (first 1-2 months):
Maintenance phase:
State-specific requirements:
The telehealth industry has grown exponentially, but not all platforms maintain the same standards. Recent enforcement actions—including criminal charges against executives of a telehealth company that inappropriately prescribed ADHD stimulants—underscore the importance of choosing wisely.
🚩 Guaranteed prescriptions before evaluation: Any platform promising medication before a thorough assessment is operating outside medical standards.
🚩 Minimal evaluation: If your ‘consultation’ is just a 5-minute questionnaire with automatic prescription, that’s not legitimate medical care.
🚩 No discussion of alternatives: Reputable providers discuss therapy, nutrition counseling, and other evidence-based approaches—not just medication.
🚩 Prescribing controlled substances for BED: While Vyvanse is FDA-approved for BED, most legitimate telehealth platforms avoid prescribing stimulants for this condition due to abuse potential and regulatory complexity.
🚩 Direct medication sales: The platform should send prescriptions to independent pharmacies, not sell you pills directly.
🚩 No licensed provider interaction: You should have a real video or phone consultation with a licensed clinician, not just submit forms.
✅ Comprehensive initial evaluation: 30+ minutes with detailed history-taking
✅ Licensed, credentialed providers: Clear information about who you’re seeing and their qualifications
✅ Transparent about limitations: Honest about what telehealth can and can’t treat, and when in-person care is needed
✅ Evidence-based approach: Treatment recommendations based on clinical guidelines and research
✅ Multidisciplinary perspective: Discusses therapy, lifestyle interventions, and other supports alongside medication
✅ Clear follow-up plan: Scheduled appointments and accessible support between visits
✅ Privacy and security: HIPAA-compliant platforms with secure messaging and video
✅ Insurance transparency: Clear information about costs, whether insurance is accepted, and cash-pay options
At Klarity Health, we’ve built our telehealth platform around the principles of safe, evidence-based, and accessible mental healthcare. Our approach to BED treatment includes:
Provider availability: We maintain a network of licensed psychiatrists, psychiatric nurse practitioners, and physician assistants across multiple states, reducing typical wait times from months to days.
Transparent pricing: We accept both insurance and cash pay, with clear upfront pricing—no surprise bills or hidden fees.
Comprehensive care: Our providers view medication as one component of BED treatment, discussing therapy referrals and lifestyle interventions as part of holistic care.
Quality standards: Every provider undergoes credentialing verification, and our clinical team reviews prescribing patterns to ensure adherence to evidence-based guidelines.
Flexible access: Beyond scheduled video appointments, patients can message their provider between visits for questions or concerns.
While telehealth expands access to care, it’s not appropriate for everyone. Providers will screen for conditions that require in-person evaluation or make certain medications unsafe:
❌ History of bulimia or anorexia nervosa: Bupropion (Wellbutrin) is contraindicated due to significantly increased seizure risk. Many providers will also be cautious with topiramate.
❌ Seizure disorder: Both commonly used medications can affect seizure threshold. While topiramate is an anticonvulsant, it requires careful monitoring; bupropion is contraindicated.
❌ Pregnancy or planning pregnancy: Topiramate carries significant teratogenic risk (birth defects, particularly cleft palate). Not recommended unless benefits clearly outweigh risks, and effective contraception is essential.
❌ Severe medical instability: Conditions requiring urgent in-person evaluation, such as:
🏥 Need for FDA-approved controlled medication: If clinical assessment suggests Vyvanse would be the most appropriate treatment, most telehealth platforms will refer you to in-person care for that prescription.
🏥 Complex psychiatric presentation: Multiple active psychiatric conditions, recent psychiatric hospitalization, or active suicidal ideation often require in-person intensive treatment.
🏥 Severe BED with medical complications: If binge eating has led to severe metabolic consequences or other urgent medical issues requiring comprehensive workup.
🏥 Limited digital access or comfort: Telehealth requires reliable internet, a device with video capability, and basic comfort with technology.
Most health insurance plans now cover telehealth mental health services at the same rate as in-person visits, thanks to parity laws and pandemic-era policy changes that have largely been made permanent.
What to verify with your insurance:
For patients without insurance or with high deductibles, many telehealth platforms offer transparent cash-pay pricing:
Typical costs:
At Klarity Health, we accept both insurance and cash pay, giving patients flexibility regardless of their coverage situation.
One advantage of non-controlled medications is the ability to provide refills without monthly prescriptions:
Refill policies:
Prescription Monitoring Programs:While not legally required for these medications, responsible providers may check your state’s PMP database to:
This is a safety measure, not surveillance—part of good medical practice.
The regulatory landscape for telehealth continues to evolve, but the trajectory is toward expansion and permanence rather than restriction:
The DEA has extended pandemic-era flexibilities for controlled substance prescribing through December 31, 2026, with a permanent rulemaking process underway. While this primarily affects controlled medications, it signals federal commitment to telehealth access.
For non-controlled medications like those used for BED, there are no expected restrictions on the horizon—telehealth prescribing is fully established and unlikely to be limited.
States are increasingly:
As of 2025, Wisconsin, Michigan, and several other states joined the ranks of full practice authority for NPs, expanding the workforce of providers who can independently treat BED via telehealth.
Increased regulatory scrutiny of telehealth platforms is actually good for patients—weeding out bad actors while establishing higher standards across the industry. Expect to see:
Do I need an in-person visit before starting medication for BED via telehealth?
In most states, no. The majority of states allow a comprehensive telehealth evaluation to establish the patient-provider relationship necessary for prescribing non-controlled medications. A few states (Alabama, Georgia, New Hampshire) may require an in-person follow-up within 6-12 months for ongoing treatment, but you can still start treatment entirely online.
Can nurse practitioners prescribe BED medications via telehealth?
Yes. In 34 states plus D.C., nurse practitioners have full independent practice authority and can prescribe these medications without physician oversight. In other states, NPs can prescribe under collaborative agreements with physicians—this is typically an administrative arrangement that doesn’t affect your care experience.
Are topiramate and bupropion FDA-approved for BED?
No—they’re prescribed off-label based on clinical evidence showing effectiveness in reducing binge eating behaviors. Off-label prescribing is legal, common, and medically appropriate when supported by research and clinical guidelines. Your provider should explain this and obtain your informed consent.
Will my telehealth provider check my prescription history?
They may, as part of good medical practice, even though it’s not legally required for non-controlled medications. This helps identify potential drug interactions and ensure comprehensive care—it’s a safety measure, not an invasion of privacy.
What if I’m pregnant or planning to become pregnant?
Topiramate is associated with birth defect risks and generally isn’t recommended during pregnancy. Your provider will discuss contraception if prescribing topiramate, and may recommend alternative approaches (like therapy-only treatment) if you’re pregnant or planning pregnancy soon.
Can I get BED treatment via telehealth if I live in a rural area?
Yes—this is one of telehealth’s greatest benefits. As long as you have internet access and your provider is licensed in your state, you can receive care regardless of geographic location.
What happens during a telehealth appointment?
You’ll have a live video (or sometimes phone) consultation with a licensed provider who will take a detailed history, assess your symptoms, discuss treatment options, and create a personalized plan. Initial visits typically last 30-45 minutes; follow-ups are usually 15-30 minutes.
How quickly can I start treatment?
This varies by platform, but many telehealth services offer appointments within days or even same-day in some cases. After your initial evaluation, if medication is appropriate, you can often pick up your prescription from the pharmacy within 24 hours.
What if I experience side effects?
Reputable telehealth platforms provide ways to contact your provider between scheduled appointments—whether through secure messaging, a nurse line, or urgent consultation requests. You should never feel stranded if you have concerns about your medication.
Does insurance cover telehealth mental health services?
Most insurance plans now cover telehealth mental health at the same rate as in-person visits. However, coverage details vary, so verify your specific plan’s telehealth benefits. Many platforms also offer affordable cash-pay options.
If you’re struggling with binge eating disorder, telehealth offers a legitimate, effective, and convenient path to evidence-based treatment. Here’s how to move forward:
Consider whether your eating patterns meet BED criteria:
Look for platforms that demonstrate:
Klarity Health offers all of these features, with a network of experienced psychiatric providers who specialize in eating disorders and evidence-based medication management, available across multiple states with both insurance and cash-pay options.
Most telehealth platforms make scheduling simple—often offering appointments within days rather than the months-long waits typical of in-person psychiatric care.
The provider can only help you with accurate information. Share openly about:
Medication works best when combined with:
Binge eating disorder is a serious but treatable condition. For too long, people struggling with BED faced significant barriers to care—from limited specialist availability to long wait times to the stigma of seeking help in person.
Telehealth has fundamentally changed this landscape. In 2026, you can receive a comprehensive evaluation, evidence-based medication management, and ongoing support from licensed providers—all via secure video appointments from wherever you are.
The legal framework is clear: non-controlled medications like topiramate and bupropion can be legally prescribed via telehealth in every U.S. state, with minimal in-person requirements. The provider network has expanded dramatically, including both psychiatrists and nurse practitioners with full prescribing authority in most states. The quality standards have matured, with reputable platforms implementing rigorous safety protocols.
Whether you’re in a major city with competitive in-person providers or a rural area with limited mental health resources, telehealth offers a path to treatment that is:
If you’re ready to take the first step toward addressing binge eating disorder, telehealth platforms like Klarity Health are here to support you with experienced providers, transparent pricing, and a commitment to quality care that puts your health and safety first.
You deserve effective treatment for BED—and in 2026, that treatment is more accessible than ever before.
Verified as of: January 4, 2026
DEA Rules Status: COVID-19 telehealth prescribing flexibilities remain in effect through December 31, 2026 (fourth extension). No federal in-person requirement exists for non-controlled medications—these were never subject to the Ryan Haight Act restrictions on telemedicine.
States Verified: Researched 10+ key states (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, SC) with latest information as of late 2025. State board sites and 2025 legislative updates were checked where available.
Sources newer than 2024: 80%+ of sources are from 2025 (many late-2025) or updated to 2025. Older sources (2024) were used only when confirmed still accurate by newer references.
⚠️ Flagged for follow-up: Alabama and South Carolina NP scope changes (legislation was discussed in 2025 but final status unclear—assume no full independence yet pending confirmation). Monitor DEA’s pending final rule on telehealth prescribing (expected by end of 2026). Verify any temporary state waivers for expiration/extension beyond 2025.
HHS Press Release (January 2026). ‘DEA Extends Telemedicine Prescribing Flexibilities Through 2026.’ Available at: https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html
Sheppard Mullin Healthcare Law Blog (August 2025). ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions.’ Available at: https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/
Center for Connected Health Policy (November-December 2025). ‘State Telehealth Laws and Reimbursement Policies: Online Prescribing.’ Available at: https://www.cchpca.org/topic/online-prescribing/
National Law Review (2024-2025). ‘Telehealth and In-Person Visits: State Updates on Pandemic-Era Exceptions.’ Available at: https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era
Health Jobs Nationwide Blog (January 2025). ‘State-by-State Guide: Expanding Roles for PAs and NPs (Updated 2025).’ Available at: https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/
Find the right provider for your needs — select your state to find expert care near you.